
Future Talks / 03.06
IDA Future Talks with Christian Grøndahl
Press Release / 01.20
SNIPR BIOME Strengthens Lead in CRISPR-based Medicines to Treat Microbiomes
Nome Magazine / 12.19
Back to the basics: CRISPR in bacteria can become the next big pharmaceutical breakthrough
Business Insights / 12.19
CRISPR Technology: Assassinating Superbugs and Creating a New Paradigm
EY / 11.19
EY Entrepreneur Of The Year 2019 / Life Sciences – video presentation of
SNIPR BIOME [in Danish]
EY / 11.19
EY Entrepreneur Of The Year 2019 / Life Sciences – video of award show [in Danish / English]
EY / 11.19
SNIPR BIOME wins the prestigious "EY Entrepreneur Of The Year 2019 / Life Sciences" award
CRISPR Medicine Blog / 11.19
Turning CRISPR into a bacteria killer. A new principle in antibiotics
Finans / 11.19
Danish biotech company to develop ground-breaking replacement for penicillin
[in Danish]
IDA / 08.19
Danish CRISPR startup to develop replacement for penicillin [in Danish]
Pharma / 06.19
The biotech company SNIPR Biome wants to hit bacteria precisely [in Danish]
Press Release / 05.19
US Patent Grants Strengthen SNIPR BIOME’s Approach to Enhance Immuno-Oncology Outcomes by Microbiome Modulation
BioCentury Innovations / 05.19
SNIPR: Turning CRISPR into a microbiome suicide
FierceBiotech / 03.19
SNIPR raises $50M to use CRISPR to modulate the microbiome
BioCentury / 03.19
$50M series A for CRISPR microbiome play SNIPR BIOME
Endpoint News / 03.19
Lundbeck fund backs a $50M launch round for SNIPR Biome, a new brand of CRISPR Cas biotech
Børsen / 03.19
Biotech baby raises DKK 320 million to develop replacement for penicillin [in Danish]
Press Release / 03.19
SNIPR BIOME raises $50 million Series A financing to advance CRISPR-based microbiome drugs to human clinical trials
Børsen / 08.17
Owner of Lundbeck stakes millions on bacteria killer SNIPR [in Danish]
Berlingske Tidene / 08.17
Owner of Lundbeck stakes millions on bacteria killers [in Danish]
Lundbeckfonden / 08.17
Owner of Lundbeck invests in CRISPR technology for bacterial gene editing
[in Danish]